Betz Stephen F.

Chief Scientific Officer

1 company

Good

Trades Analyzed

12M Win Rate

57.1%

Avg 3M Return

+4.3%

Avg 12M Return

-3.4%

Betz Stephen F. is a Chief Scientific Officer at Crinetics Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 11 sells.

Estimated insider holdings value: $5.5M based on current market prices.

Holdings by Company

CRNXFeb 23, 2026

Current Shares147.7K

Value$5.54M

Net Activity-285,875

Bought: 0Sold: 285.9K

Showing 10 filings (page 4)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 18, 2022	CRNX Crinetics Pharmaceuticals, Inc.	Chief Scientific Officer	Sell	5,664	$25.81	$146,187.84	-4.9%	-15.4%	-26.5%
Apr 4, 2022	CRNX Crinetics Pharmaceuticals, Inc.	Chief Scientific Officer	Sell	9,000	$23.97	$215,761.50	-7.2%	-19.3%	-34.1%
Apr 1, 2022	CRNX Crinetics Pharmaceuticals, Inc.	Chief Scientific Officer	Sell	8,328	$21.43	$178,474.87	-3.2%	-20.9%	-31.9%
Mar 15, 2022	CRNX Crinetics Pharmaceuticals, Inc.	Chief Scientific Officer	Sell	3,123	$18.94	$59,149.62	-2.3%	-10.0%	-9.9%
Mar 1, 2022	CRNX Crinetics Pharmaceuticals, Inc.	Chief Scientific Officer	Sell	3,123	$19.73	$61,616.79	-2.2%	-14.4%	+0.4%
Feb 15, 2022	CRNX Crinetics Pharmaceuticals, Inc.	Chief Scientific Officer	Sell	3,123	$18.64	$58,212.72	-2.5%	+2.8%	+1.2%
Feb 1, 2022	CRNX Crinetics Pharmaceuticals, Inc.	Chief Scientific Officer	Sell	3,123	$18.79	$58,681.17	-2.4%	+7.6%	+6.2%
Jan 18, 2022	CRNX Crinetics Pharmaceuticals, Inc.	Chief Scientific Officer	Sell	4,168	$23.29	$97,072.72	-3.1%	+6.4%	-12.8%
Jan 3, 2022	CRNX Crinetics Pharmaceuticals, Inc.	Chief Scientific Officer	Sell	7,168	$28.02	$200,847.36	-5.1%	-12.9%	-36.1%
Dec 28, 2021	CRNX Crinetics Pharmaceuticals, Inc.	Chief Scientific Officer	Sell	3,000	$27.95	$83,851.80	-2.1%	-29.4%	-36.2%